France Bone Void Fillers Market Size, Share, and COVID-19 Impact Analysis, By Type (Demineralized Bone Matrix, Collagen Matrix), By End-User (Hospital, Clinics, Others), and France Bone Void Fillers Market Insights Forecasts to 2033

Industry: Healthcare

RELEASE DATE Apr 2024
REPORT ID SI4209
PAGES 200
REPORT FORMAT PathSoft

France Bone Void Fillers Market Insights Forecasts to 2033

  • The France Bone Void Fillers Market Size was valued at USD 118.45 Million in 2023.
  • The Market Size is Growing at a CAGR of 5.54% from 2023 to 2033.
  • The France Bone Void Fillers Market Size is Expected to Reach USD 203.13 Million by 2033.

 

 France Bone Void Fillers Market

Get more details on this report -

Request Free Sample PDF

 

The France Bone Void Fillers Market Size is Expected to Reach USD 203.13 Million by 2033, at a CAGR of 5.54% during the forecast period 2023 to 2033.

 

Market Overview

Bone void Filters is a synthetic bone void fillers that can be injected, molded, and drilled. It contains 40% hydroxyapatite, 60% calcium sulfate, and the radiocontrast agent iohexol. Cements' unique hydroxyapatite-calcium sulfate ratio allows it to resorb at the same pace as bone. Fillers such as collagen serve an important role in orthopedic treatments such as fracture fixation, joint reconstruction, and spinal fusion, contributing to better clinical outcomes and patient satisfaction. The need for bone void fillers is fueled by joint replacement surgeries, which are frequently required due to age-related disorders including arthritis. These fillers contribute significantly to the success of joint replacement surgeries by providing support and assisting with implant integration. The older population's tendency to continue an active lifestyle increases the demand for such joint-preserving therapies. The France healthcare system is adapting to the changing demographic environment, taking into account the elderly's special healthcare needs. This adaptation includes incorporating sophisticated orthopedic solutions, such as bone void fillers, into treatment plans. Healthcare providers are progressively incorporating these interventions into their offerings to meet the special needs of an ageing patient population.

 

Report Coverage

This research report categorizes the market for France bone void fillers market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France bone void fillers market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segments of the France bone void fillers market.

 

France Bone Void Fillers Market Report Coverage

Report CoverageDetails
Base Year:2023
Market Size in 2023:USD 118.45 Million
Forecast Period:2023 - 2033
Forecast Period CAGR 2023 - 2033 : 5.54%
2033 Value Projection:USD 203.13 Million
No. of Pages:200
Tables, Charts & Figures:110
Segments covered:By Type, By End-User
Companies covered:: Stryker France SASU, Johnson & Johnson Santé Beauté France, Integra LifeSciences Services France SASU, Zimmer Biomet Holdings, Inc, Smith Nephew, Medtronic, Plc, Arthrex France, and Others
Pitfalls & Challenges:COVID-19 Empact, Challenges, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The rising use of synthetic bone void fillers like calcium sulfate and tricalcium phosphate is likely to fuel market expansion. These fillers have various advantages over other bone transplant alternatives, including high sterility, low morbidity risk, and an unlimited supply. This is likely to increase product demand throughout the projection period in France. The filters are made of tri-calcium phosphate, an osteoconductive calcium phosphate that is thought to have the closest chemical makeup to human bones. In addition, important players such as BONESUPPORT AB and Bio Composites have launched synthetic products. These companies have grown rapidly in recent years as their products have become more widely adopted.

 

Restraining Factors

The developing clinical limits and low penetration of bone void-filling materials resulted in a decrease in their usage. The low adoption rate can be attributed to the considerable dangers associated with using the substance. These include unfavorable tissue reactions, inadequate or non-existent bone development, soft tissue and bone infection, and filler rupture with or without particle formation.

 

Market Segment

  • In 2023, the demineralized bone matrix segment accounted for the largest revenue share over the forecast period.

Based on the type, the France bone void fillers market is segmented into demineralized bone matrix and collagen matrix. Among these, the demineralized bone matrix segment has the largest revenue share over the forecast period. Demineralized, generated from allograft bone, has a unique combination of osteoinductive and osteoconductive features that promote bone repair. Its capacity to encourage new bone development makes it an ideal choice for a variety of orthopedic treatments. The collagen matrix also has a major proportion due to its biocompatibility and capacity to act as a scaffold for tissue formation.

 

  • In 2023, the hospitals segment accounted for the largest revenue share over the forecast period.

On the basis of end user, the France bone void fillers market is segmented into hospitals, clinics, and others. Among these, the hospitals segment has the largest revenue share over the forecast period. Hospitals, with their extensive range of medical services and facilities, typically handle a significant share of orthopedic operations and related treatments, boosting demand for bone void fillers. The hospitals  frequently deal with a broad patient population, including those with complex orthopedic diseases, therefore bone void fillers are an essential component of their medical arsenal.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France bone void fillers market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Stryker France SASU
  • Johnson & Johnson Santé Beauté France
  • Integra LifeSciences Services France SASU
  • Zimmer Biomet Holdings, Inc
  • Smith Nephew
  • Medtronic, Plc
  • Arthrex France
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at regional, and country levels from 2022 to 2033. Spherical Insights has segmented the France Bone Void Fillers Market based on the below-mentioned segments:

 

France Bone Void Fillers Market, By Type

  • Demineralized Bone Matrix
  • Collagen Matrix

 

France Bone Void Fillers Market, By End User

  • Hospital
  • Clinics
  • Others

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies